SCOTTSDALE, AZ–(Marketwired – April 15, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) is offering select breast reconstruction surgeons across the U.S. and Canada zero-cost access to what we aim to be the fastest and most clinically predictive cancer diagnostic. This unique opportunity comes on the heels of the commencement of the Company’s revolutionary new […]